HUP0401323A2 - IL-18 inhibitorok alkalmazása túlérzékenységi rendellenességek esetén - Google Patents

IL-18 inhibitorok alkalmazása túlérzékenységi rendellenességek esetén

Info

Publication number
HUP0401323A2
HUP0401323A2 HU0401323A HUP0401323A HUP0401323A2 HU P0401323 A2 HUP0401323 A2 HU P0401323A2 HU 0401323 A HU0401323 A HU 0401323A HU P0401323 A HUP0401323 A HU P0401323A HU P0401323 A2 HUP0401323 A2 HU P0401323A2
Authority
HU
Hungary
Prior art keywords
inhibitors
hypersensitivity disorders
hypersensitivity
disorders
inhibitor
Prior art date
Application number
HU0401323A
Other languages
English (en)
Inventor
Yolande Chvatchko
Marie Kosco-Vilbois
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of HUP0401323A2 publication Critical patent/HUP0401323A2/hu
Publication of HUP0401323A3 publication Critical patent/HUP0401323A3/hu
Publication of HU230377B1 publication Critical patent/HU230377B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya IL-18-inhibitor alkalmazása a túlérzékenységirendellenességek, különösen a késleltetett típusú túlérzékenység,kezelésére és/vagy megelőzésére szolgáló gyógyszer előállítására. Ó
HU0401323A 2001-08-10 2002-08-01 IL-18 inhibitorok alkalmazása túlérzékenységi rendellenességek esetén HU230377B1 (hu)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP01118811.7 2001-08-10
EP02100735 2002-06-20
EP02100735.6 2002-06-20
PCT/EP2002/008591 WO2003013577A2 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (3)

Publication Number Publication Date
HUP0401323A2 true HUP0401323A2 (hu) 2004-10-28
HUP0401323A3 HUP0401323A3 (en) 2006-01-30
HU230377B1 HU230377B1 (hu) 2016-03-29

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401323A HU230377B1 (hu) 2001-08-10 2002-08-01 IL-18 inhibitorok alkalmazása túlérzékenységi rendellenességek esetén

Country Status (27)

Country Link
US (1) US20040247598A1 (hu)
EP (1) EP1423138B1 (hu)
JP (1) JP4301942B2 (hu)
KR (1) KR20040030948A (hu)
CN (1) CN100500210C (hu)
AR (1) AR035274A1 (hu)
AU (1) AU2002331376B2 (hu)
BR (1) BRPI0211827B8 (hu)
CA (1) CA2456247C (hu)
CY (1) CY1116137T1 (hu)
DK (1) DK1423138T3 (hu)
EA (1) EA006745B1 (hu)
ES (1) ES2533253T3 (hu)
HK (1) HK1069780A1 (hu)
HR (1) HRP20040071B1 (hu)
HU (1) HU230377B1 (hu)
IL (2) IL160230A0 (hu)
ME (1) ME00547B (hu)
MX (1) MXPA04001230A (hu)
NO (1) NO335688B1 (hu)
PL (1) PL227130B1 (hu)
PT (1) PT1423138E (hu)
RS (1) RS52224B (hu)
SI (1) SI1423138T1 (hu)
UA (1) UA78516C2 (hu)
WO (1) WO2003013577A2 (hu)
ZA (1) ZA200400442B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006003927A1 (ja) * 2004-06-30 2006-01-12 Atsuo Sekiyama 非炎症性ストレス応答の指標剤およびその利用
SI2267024T1 (sl) 2005-06-03 2012-09-28 Ares Trading Sa Proizvodnja rekombinantnega IL-18 vezavnega proteina
CA2610804C (en) 2005-06-10 2013-11-19 Ares Trading S.A. Process for the purification of il-18 binding protein
ES2514495T3 (es) 2006-05-25 2014-10-28 Glaxo Group Limited Anticuerpos humanizados modificados anti-interleucina-18
WO2012081650A1 (ja) * 2010-12-16 2012-06-21 株式会社明治 遅延型過敏症軽減剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
DE69925581T2 (de) * 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
BR9816013A (pt) * 1998-09-01 2003-01-21 Hayashibara Biochem Lab Proteìna de ligação de interleucina-18
WO2000071719A1 (en) * 1999-05-20 2000-11-30 Hyseq, Inc. Interleukin-1 hy2 materials and methods
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
WO2003013577A3 (en) 2003-09-25
NO335688B1 (no) 2015-01-19
US20040247598A1 (en) 2004-12-09
EP1423138B1 (en) 2014-12-24
HRP20040071B1 (hr) 2015-08-28
BRPI0211827B8 (pt) 2021-05-25
CN1568193A (zh) 2005-01-19
PL227130B1 (pl) 2017-10-31
RS52224B (sr) 2012-10-31
CA2456247C (en) 2013-09-10
EA200400296A1 (ru) 2004-06-24
JP4301942B2 (ja) 2009-07-22
CY1116137T1 (el) 2017-02-08
BRPI0211827B1 (pt) 2019-07-23
NO20040370L (no) 2004-03-23
WO2003013577A2 (en) 2003-02-20
PT1423138E (pt) 2015-02-09
SI1423138T1 (sl) 2015-04-30
EP1423138A2 (en) 2004-06-02
BR0211827A (pt) 2004-08-31
DK1423138T3 (en) 2015-02-23
MXPA04001230A (es) 2004-05-27
AR035274A1 (es) 2004-05-05
HK1069780A1 (en) 2005-06-03
JP2005501080A (ja) 2005-01-13
PL368231A1 (en) 2005-03-21
CN100500210C (zh) 2009-06-17
HRP20040071A2 (en) 2004-10-31
KR20040030948A (ko) 2004-04-09
ZA200400442B (en) 2005-03-30
AU2002331376B2 (en) 2007-06-14
ME00547B (me) 2011-12-20
UA78516C2 (en) 2007-04-10
IL160230A (en) 2014-11-30
EA006745B1 (ru) 2006-04-28
YU11904A (sh) 2006-08-17
CA2456247A1 (en) 2003-02-20
ES2533253T3 (es) 2015-04-08
HUP0401323A3 (en) 2006-01-30
IL160230A0 (en) 2004-07-25
HU230377B1 (hu) 2016-03-29

Similar Documents

Publication Publication Date Title
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
NO20034056D0 (no) Proliferative sykdommer
SI1487541T1 (sl) Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
WO2003042246A3 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
NO20100477L (no) Anvendelse av risendronat til fremstilling av medikamenter for behandling og prevensjon av osteoporose
AU2003291342A1 (en) Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
GB0226434D0 (en) Combination product
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
NO20035025D0 (no) Anvendelse av osteopontin for behandling og/eller for å hindre nevrologiskesykdommer
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
MXPA06002722A (es) Composicion farmaceutica que comprende un antagonista del receptor p2x7 y un farmaco anti-inflamatorio no esteroidal.
HUP0401854A2 (hu) COX-2 inhibitorokat és aszpirint tartalmazó kombinációk
PT1404304E (pt) Comprimido contendo cetirizina e pseudoefedrina
TW200507829A (en) New combination
CY1116137T1 (el) Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
HUP0302738A2 (hu) SARP-1 alkalmazása scleroderma kezelésére és megelőzésére
GEP20104888B (en) Use of carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders